MCP AbD Serotec
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     



This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Glossary
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Lausted, C. G.
Right arrow Articles by Hood, L. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lausted, C. G.
Right arrow Articles by Hood, L. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on March 18, 2008
Revised on August 1, 2008
Accepted on August 3, 2008

Quantitative serum proteomics from surface plasmon resonance imaging

Christopher G. Lausted, Zhiyuan Hu, and Leroy E. Hood

Institute for Systems Biology, Seattle, WA 98103-8904

Corresponding Author: clausted{at}systemsbiology.org

The detection and quantification of specific proteins in complex mixtures is a major challenge for proteomics. For example, the development of disease-related biomarker panels will require fast and efficient methods for obtaining multi-parameter protein profiles. We established a high-throughput, label-free method for analyzing serum using Surface Plasmon Resonance (SPR) imaging of antibody microarrays. Microarrays were fabricated using standard pin spotting on bare gold substrates and samples were applied for binding analysis using a camera-based SPR system. We validated the system by measuring the concentrations of four serum proteins using part of a 792-feature microarray. Transferrin concentrations were measured to be 2.1 mg/mL in human serum and 1.2 mg/mL in murine serum, which closely matched ELISA determinations of 2.6 and 1.2 mg/mL, respectively. In agreement with expected values, human and mouse albumin levels were measured to be 24.3 and 23.6 mg/ml, respectively. The lower limits of detection for the four measurements ranged from 14 to 58 ng/ml, or 175 to 755 pM. Where purified target proteins are not available for calibration, the microarrays can be used for relative protein quantification. We used the antibody microarray to compare the serum protein profiles from three liver cancer patients and three non-liver cancer patients. Hierarchical clustering of the serum protein levels clearly distinguished two distinct profiles. Thirty-nine significant protein changes were detected (P<0.05), ten of which have been previously observed in serum. Alpha fetoprotein, a known liver cancer marker, was observed to increase. These results demonstrate the feasibility of this high-throughput approach for both absolute and relative protein expression profiling.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.